💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
User | Tweets |
---|---|
@newsfilterio | 9 |
@Tickeron | 8 |
@sleekoptions | 6 |
@MarcJacksonLA | 5 |
@TradeWithAlerts | 5 |
![]() |
@sleekoptions $INCY Was up 1.26 %. Turned negative -0.01% | (Green to red move) #GreenToRed https://t.co/GVxlCwgmt1 https://t.co/xgQfS3N7CR 2:04am |
![]() |
@newsfilterio Incyte and Morphosys dose first patient in late-stage lymphoma study $INCY $MOR https://t.co/4IdM9PQlnY 12:04am |
![]() |
@Briefingcom $INCY: Incyte and MorphoSys AG (MOR) announce that the first patient has been dosed in the placebo-controlled Phase… https://t.co/2mjdQJfFTL April 19th 2021, 10:04pm |
![]() |
@otcdynamics $INCY Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasita… https://t.co/VQ6cN566o1 April 19th 2021, 8:04pm |
![]() |
@MarcJacksonLA $INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Taf… https://t.co/SbiY8fxM54 April 19th 2021, 8:04pm |
![]() |
@biotechradar_eu Incyte $INCY and MorphoSys $MOR Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Taf… https://t.co/w5LbW4oenj April 19th 2021, 8:04pm |
![]() |
@stock_titan $INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Taf… https://t.co/7pNixbP8fb April 19th 2021, 8:04pm |
![]() |
@sleekoptions $INCY Was up 1.26 %. Turned negative -0.51% | (Green to red move) #GreenToRed https://t.co/GVxlCvYL4r https://t.co/r785sEUfh1 April 19th 2021, 3:04pm |
![]() |
@MarcJacksonLA $INCY Buy or Fear Incyte’s Stock: INCY’s 17% Decline In A Year Despite Revenues Increasing 17% YoY Over The Last 4… https://t.co/XZITjzGbfp April 19th 2021, 2:04pm |
![]() |
@mediasentiment $INCY new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 190 April 18th 2021, 9:04pm |
![]() |
@Tickeron $INCY in Downtrend: its price may drop because broke its higher Bollinger Band on April 1, 2021. View odds for this… https://t.co/M6NeVOV2B4 April 18th 2021, 9:04pm |
![]() |
@communiststocks Incyte - $INCY ? QUOTE $INCY was DOWN ? on Fri Apr 16 Closed at 82.68 USD for a -0.62% loss from previous close ?… https://t.co/sTx99j9KXK April 18th 2021, 8:04am |
![]() |
@ms101phd $LLY $INCY Eli Lilly and Incyte was another overhyped and rushed phase 3 antiviral trial failure with Baricitinib.… https://t.co/w2L1zVxE4F April 17th 2021, 2:04pm |
![]() |
@optioncharts $INCY open interest for maturity 05/21/2021. High put=80.00 High call=85.00 PutCallRatio=0.30 #maxpain #options… https://t.co/m4GXbJ41EA April 17th 2021, 1:04pm |
![]() |
@PorqueNoTrade $INCY With $LLY, aricitinib fails to meet main goal in late-stage COVID-19 trial #Stocks #Trading #TradingNews #StockMarketNews #PQNews April 17th 2021, 9:04am |
![]() |
@newsfilterio Incyte: What Falling Off A Cliff Looks Like $INCY https://t.co/pqhRaaKTJ6 April 17th 2021, 6:04am |
![]() |
@QuantData Incyte Corp Trial Did Not Meet Statistical Significance On Primary Endpoint Related Tickers: $INCY Read more at: https://t.co/Z7qrfq34mm April 16th 2021, 8:04pm |
![]() |
@newsfilterio Lilly and Incyte's baricitinib fails to meet main goal in late-stage COVID-19 trial $LLY $INCY https://t.co/6cNyVOuqiM April 16th 2021, 8:04pm |
![]() |
@Globalmess65 $INCY trial did not meet end point April 16th 2021, 8:04pm |
![]() |
@Tickeron $INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/QYdeVQJrVn April 16th 2021, 8:04pm |
![]() |
@StckPro $INCY NEW ARTICLE : Incyte: What Falling Off A (Patent) Cliff Looks Like https://t.co/TCHNd4q0AO Get all the latest… https://t.co/8PERy0eS97 April 16th 2021, 1:04pm |
![]() |
@SeekingAlpha $INCY - Incyte: What Falling Off A (Patent) Cliff Looks Like. https://t.co/rlAf3BlMHC #trading #economy #finance April 16th 2021, 1:04pm |
![]() |
@SwingTradeBot Recent $INCY technical alerts: MACD Bullish Centerline Cross plus 7 more alerts... https://t.co/w5vDMJe2Lv April 16th 2021, 1:04pm |
![]() |
@StockTexts $INCY Incyte Corporation SEC Filing: Form DEF 14A https://t.co/gf3YyQXWnu April 16th 2021, 12:04pm |
![]() |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in INCYTE $INCY https://t.co/wfb6FB7BrL April 16th 2021, 12:04pm |
![]() |
@FlashAlert_me $INCY [15s. delayed] filed form DEFA14A on April 16, 08:16:29 https://t.co/u0ms53rIl1 April 16th 2021, 12:04pm |
![]() |
@FlashAlert_me $INCY [15s. delayed] filed form DEF 14A on April 16, 08:15:23 https://t.co/DRrRu9aavJ April 16th 2021, 12:04pm |
![]() |
@fintel_io $INCY / Incyte files form DEF 14A https://t.co/Oc4NyYycjO April 16th 2021, 12:04pm |
![]() |
@Tickeron $INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/XApO2SezHB April 15th 2021, 9:04pm |
![]() |
@CarlosCarloan @unusual_whales He did this with $INCY, touted it in the 140s, hasn’t sniffed that number in the 4 years since. April 15th 2021, 2:04am |
![]() |
@TradeWithAlerts Large Print $INCY Size: 148890 Price: 82.21 Time: 1600 Amount: $12,240,246.90 April 14th 2021, 8:04pm |
![]() |
@optioncharts $INCY high OI range is 80.00 to 87.50 for option expiration 04/16/2021 PutCallRatio=0.38 #maxpain #options… https://t.co/QLzpWrlg33 April 14th 2021, 10:04am |
![]() |
@newsfilterio Incyte to Report First Quarter Financial Results $INCY https://t.co/niy9kzmuNb April 14th 2021, 5:04am |
![]() |
@savage_swings $INCY #Earnings 5/3 At trend line support. https://t.co/XyMJs25TyC April 13th 2021, 11:04pm |
![]() |
@InsiderAlerts4U $INCY: New Insider Filing on INCYTE CORP's EVP & General Counsel MARIA E PASQUALE: https://t.co/tmYOzRgLpl April 13th 2021, 8:04pm |
![]() |
@FlashAlert_me $INCY [15s. delayed] filed SEC form 4: EVP & General Counsel Pasquale Maria E: Delivered securities 517 of Common… https://t.co/g4tSrqT56q April 13th 2021, 8:04pm |
![]() |
@TradeWithAlerts Large Print $INCY Size: 261020 Price: 80.65 Time: 1600 Amount: $21,051,263.00 April 13th 2021, 8:04pm |
![]() |
@equity_newswire $INCY Incyte to Report First Quarter Financial Results https://t.co/2djeO7tkg7 April 13th 2021, 6:04pm |
![]() |
@A1Syad $INCY // Signals could not be any clearer on the 5-minute chart of INCY!!.. https://t.co/z0NXYn9tOs April 13th 2021, 6:04pm |
![]() |
@Tickeron $INCY in Downtrend: Stochastic indicator leaves overbought zone. View odds for this and other indicators:… https://t.co/TacPJwhTO1 April 13th 2021, 3:04pm |
![]() |
@FlashAlert_me $INCY [15s. delayed]: Issued Press Release on April 13, 08:00:00: Incyte to Report First Quarter Financial Results https://t.co/9BLhWdw8Xi April 13th 2021, 12:04pm |
![]() |
@stock_titan $INCY Incyte to Report First Quarter Financial Results https://t.co/2NWOB5vbBr April 13th 2021, 12:04pm |
![]() |
@SeekingAlpha $INCY - Incyte Corporation (INCY) Presents at AACR Virtual Meeting 2021 - Slideshow. https://t.co/0UtBMJrqFu #business #stockmarket #finance April 12th 2021, 7:04pm |
![]() |
@Gambiste1 RT @OptionsLeague: $INCY Update from AACR on the adenosine programs; Reiterate BUY https://t.co/6W9tTReOLX credit: @WallStJesus April 12th 2021, 5:04pm |
![]() |
@OptionsLeague $INCY Update from AACR on the adenosine programs; Reiterate BUY https://t.co/6W9tTReOLX credit: @WallStJesus April 12th 2021, 4:04pm |
![]() |
@sole_nyc23 RT @WallStJesus: $INCY Update from AACR on the adenosine programs; Reiterate BUY https://t.co/gNrK6ugtds April 12th 2021, 4:04pm |
![]() |
@WallStJesus $INCY Update from AACR on the adenosine programs; Reiterate BUY https://t.co/gNrK6ugtds April 12th 2021, 4:04pm |
![]() |
@optioncharts $INCY Implied Volatility expiration 04/16/2021 #maxpain #options https://t.co/PJHtr5kpDR https://t.co/AzyxblTyhQ April 12th 2021, 12:04pm |
![]() |
@TVMoneymakero $INCY chart https://t.co/SvowrR3Ao5 via https://t.co/CoKk1OcPOi April 12th 2021, 4:04am |
![]() |
@Tickeron $INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators:… https://t.co/XSdckBH40H April 11th 2021, 10:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.